This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

UnitedHealth, EMIS ‘considering options’ after UK regulator refers deal to in-depth probe

By Andrew Boyce ( March 31, 2023, 10:37 GMT | Insight) -- UnitedHealth faces an in-depth UK probe into its plan to buy EMIS, a major provider of software to the country's state-funded healthcare service, after the Competition and Markets Authority rejected an offer to sell off assets to address competition concerns. The companies "are currently considering their options and will provide a further update with regards to the acquisition in due course.”UnitedHealth faces an in-depth UK probe into its plan to buy EMIS, a major provider of software to the country's state-funded healthcare service, after its offer to sell off assets to address competition concerns was rejected....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login